Fourth dose of anti-covid vaccine, today – on the day when the recommendation for administration to some risk categories arrives in Germany – also in Italy the debate among experts on the possibility of a new recall, especially for the frail, is opening up. “We should wait to understand how the circulation of the virus will go from March onwards” but “if in the autumn there is a need for a booster it could be a recommendation to get vaccinated and not an obligation, perhaps for the immunosuppressed and the frail an evaluation should be made to leaves “, epidemiologist Pier comments to Adnkronos Salute Luigi Lopalco, professor of hygiene at the University of Salento. “On the fourth dose – insists Lopalco – we must also verify the scientific evidence that is coming and will arrive”.
“We have to face the problem of the fourth dose in a very secular way, not taking it for granted but not excluding the administration, we see the data that emerge and then we will make the choices. Choices that can also be differentiated according to the immunological status, for example the compromise of the immune system for pathologies or for genetic reasons “, underlines then Franco Locatellicoordinator of the Technical Scientific Committee (Cts), guest of ‘Buongiorno’ on SkyTg24.
The European Medicines Agency (EMA) “suggested considering the fourth dose of Covid-19 vaccine only for the immunocompromised. Given that many people in this category received the third dose over 4 months ago, it is hoped a timely decision on the matter by the Italian Medicines Agency (Aifa) and the Ministry of Health “, says Nino Cartabellotta, president of the Gimbe Foundation, in the weekly report on Covid-19.
#Fourth #dose #covid #vaccine #Italy #experts